Clinical Research Directory
Browse clinical research sites, groups, and studies.
Evaluate the Safety and Efficacy of HL-1186 Tablet for Postoperative Pain Management in Abdominal Surgery
Sponsor: Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.
Summary
This is a multiple-center, randomized, double-blind, placebo-controlled study design evaluating the safety, efficacy, and pharmacokinetics (PK) parameter of HL-1186 tablet for postoperative pain management in abdominal surgery.
Official title: A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel-group Phase Ⅱa Study to Evaluate the Safety and Efficacy of HL-1186 Tablets for Postoperative Pain Management in Abdominal Surgery
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2025-12
Completion Date
2026-03
Last Updated
2025-12-30
Healthy Volunteers
No
Interventions
HL-1186
HL-1186 tablet for oral administration.
HL-1186 placebo
HL-1186 placebo tablet for oral administration.
Locations (1)
The Third Xiangya Hospital of Central South University
Changsha, Hunan, China